Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Mechanisms of Ultrasound Neuromodulation Effects in Diabetes

NCT: NCT06042517 · RECRUITING

NCT IDNCT06042517
StatusRECRUITING
Start Date2023-09-30
Completion2027-09-30
SponsorYale University (OTHER)
First posted
Last updated

Brief Summary

This study aims to evaluate the effect of hepatic ultrasound treatment on changes from baseline in whole-body insulin sensitivity during a hyperinsulinemic, euglycemic clamp (HE Clamp).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑